Journal of Bone and Mineral Metabolism

, Volume 26, Issue 6, pp 648–652 | Cite as

Grebe-type chondrodysplasia: a novel missense mutation in a conserved cysteine of the growth differentiation factor 5

  • Muhammad Faiyaz-Ul-Haque
  • Eissa A. Faqeih
  • Hamad Al-Zaidan
  • Amal Al-Shammary
  • Syed H. E. Zaidi
Short Communication


Grebe-type chondrodysplasia is a congenital skeletal disorder that is characterized by markedly shortened limbs and very short digits. This defect has an autosomal recessive mode of inheritance and results from mutations in the growth differentiation factor 5 (GDF5) gene. Here, we report three affected children in a consanguineous family who display typical features of Grebe-type chondrodysplasia. Sequencing of the GDF5 genes of the affected children identified a novel c.1285T>C mutation encoding a p.Cys429Arg substitution. The Cys429 of human GDF5 belongs to a group of seven cysteines, which are highly conserved across species and among the various members of the transforming factor-beta (TGF-β) super family of proteins. These cysteines are essential for the structure, processing, and activity of these proteins. Therefore, it is possible that the p.Cys429Arg change in the GDF5 has produced an inactive protein, resulting in a Grebe-type chondrodysplasia phenotype in the affected children. The absence of skeletal abnormalities in the carrier parents suggests that the p.Cys429Arg change did not produce a dominant negative effect or haploinsufficiency in these individuals. This finding differs from the previous report of skeletal abnormalities in heterozygous individuals of Grebe-type chondrodysplasia families.

Key words

autosomal recessive CDMP-1 GDF5 Grebe-type chondrodysplasia mutation in conserved cysteine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Costa T, Ramsby G, Cassia F, Peters KR, Soares J, Correa J, Quelce-Salgado A, Tsipouras P (1998) Grebe syndrome: clinical and radiographic findings in affected individuals and heterozygous carriers. Am J Med Genet 75(5):523–529PubMedCrossRefGoogle Scholar
  2. 2.
    Feng B, Chen RB, Luo JG, Chen RG, Zheng YM (1985) A kindred of Miao nationality affected with Grebe-Quelce-Salgado achondrogenesis. Acta Genet. Sinica 12:378–386Google Scholar
  3. 3.
    Quelce-Salgado A (1964) A new type of dwarfism with various bone aplasias and hypoplasias of the extremities. Acta Genet Stat Med 14:63–66PubMedGoogle Scholar
  4. 4.
    Stelzer C, Winterpacht A, Spranger J, Zabel B (2003) Grebe dysplasia and the spectrum of CDMP1 mutations. Pediatr Pathol Mol Med 22(1):77–85PubMedCrossRefGoogle Scholar
  5. 5.
    Thomas JT, Kilpatrick MW, Lin K, Erlacher L, Lembessis P, Costa T, Tsipouras P, Luyten FP (1997) Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 17(1):58–64PubMedCrossRefGoogle Scholar
  6. 6.
    Al-Yahyaee SA, Al-Kindi MN, Habbal O, Kumar DS (2003) Clinical and molecular analysis of Grebe acromesomelic dysplasia in an Omani family. Am J Med Genet A 121(1):9–14CrossRefGoogle Scholar
  7. 7.
    Curtis D (1986) Heterozygote expression in Grebe chondrodysplasia. Clin Genet 29(5):455–456PubMedCrossRefGoogle Scholar
  8. 8.
    Munoz Rojas MV, Goncalves LF (2002) Grebe-Quelce-Salgado chondrodystrophy: prenatal diagnosis of two new cases in unrelated families in Southern Brazil. Am J Med Genet 113(2): 193–199PubMedCrossRefGoogle Scholar
  9. 9.
    Meera Khan P, Khan A (1982) Grebe chondrodysplasia in three generations of an Andhra family in India. Prog Clin Biol Res 104:69–80PubMedGoogle Scholar
  10. 10.
    Rao N, Joseph B (2002) Grebe syndrome with bilateral fibular hemimelia and thumb duplication. Skeletal Radiol 31(3):183–187PubMedCrossRefGoogle Scholar
  11. 11.
    Faiyaz-Ul-Haque M, Ahmad W, Wahab A, Haque S, Azim AC, Zaidi SH, Teebi AS, Ahmad M, Cohn DH, Siddique T, Tsui LC 2002 Frameshift mutation in the cartilage-derived morphogenetic protein 1 (CDMP1) gene and severe acromesomelic chondrodysplasia resembling Grebe-type chondrodysplasia. Am J Med Genet 111(1):31–37PubMedCrossRefGoogle Scholar
  12. 12.
    Kumar D, Curtis D, Blank CE (1984) Grebe chondrodysplasia and brachydactyly in a family. Clin Genet 25(1):68–72PubMedCrossRefGoogle Scholar
  13. 13.
    Lin AE, Wheeler PG, Smith R (2001) Grebe syndrome in Vietnamese sisters: not Agent Orange. Clin Genet 59(1):25–27PubMedCrossRefGoogle Scholar
  14. 14.
    Hattab FN, al-Khateeb T, Mansour M (1996) Oral manifestations of severe short-limb dwarfism resembling Grebe chondrodysplasia: report of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81(5):550–555PubMedCrossRefGoogle Scholar
  15. 15.
    Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215PubMedCrossRefGoogle Scholar
  16. 16.
    Romeo G, Zonana J, Lachman RS, Opitz JM, Scott CI Jr, Spranger JW, Rimoin DL (1977) Grebe chondrodysplasia and similar forms of severe short-limbed dwarfism. Birth Defects Orig Artic Ser 13(3C):109–115PubMedGoogle Scholar
  17. 17.
    Teebi AS, Al-Awadi SA, Opitz JM, Spranger J (1986) Severe short-limb dwarfism resembling Grebe chondrodysplasia. Hum Genet 74(4):386–390PubMedCrossRefGoogle Scholar
  18. 18.
    Storm EE, Kingsley DM (1996) Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development (Camb) 122(12): 3969–3979Google Scholar
  19. 19.
    Francis-West PH, Abdelfattah A, Chen P, Allen C, Parish J, Ladher R, Allen S, MacPherson S, Luyten FP, Archer CW (1999) Mechanisms of GDF-5 action during skeletal development. Development (Camb) 126(6):1305–1315Google Scholar
  20. 20.
    Storm EE, Kingsley DM (1999) GDF5 coordinates bone and joint formation during digit development. Dev Biol 209(1):11–27PubMedCrossRefGoogle Scholar
  21. 21.
    Brunner AM, Lioubin MN, Marquardt H, Malacko AR, Wang WC, Shapiro RA, Neubauer M, Cook J, Madisen L, Purchio AF (1992) Site-directed mutagenesis of glycosylation sites in the transforming growth factor-beta 1 (TGF beta 1) and TGF beta 2 (414) precursors and of cysteine residues within mature TGF beta 1: effects on secretion and bioactivity. Mol Endocrinol 6(10): 1691–1700PubMedCrossRefGoogle Scholar
  22. 22.
    Seemann P, Schwappacher R, Kjaer KW, Krakow D, Lehmann K, Dawson K, Stricker S, Pohl J, Ploger F, Staub E, Nickel J, Sebald W, Knaus P, Mundlos S (2005) Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. J Clin Invest 115(9):2373–2381PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2008

Authors and Affiliations

  • Muhammad Faiyaz-Ul-Haque
    • 1
  • Eissa A. Faqeih
    • 2
  • Hamad Al-Zaidan
    • 3
  • Amal Al-Shammary
    • 1
  • Syed H. E. Zaidi
    • 4
  1. 1.Molecular Genetics Laboratory, Department of Pathology & Laboratory MedicineKing Faisal Specialist Hospital & Research CentreRiyadhSaudi Arabia
  2. 2.Department of Pediatric MedicineChildren’s Hospital, King Fahad Medical CityRiyadhSaudi Arabia
  3. 3.Department of Medical GeneticsKing Faisal Specialist Hospital & Research CentreRiyadhSaudi Arabia
  4. 4.Department of MedicineUniversity Health Network & University of TorontoTorontoCanada

Personalised recommendations